US 12,454,527 B2
Conjugate monomethyl auristatin E to obtain a composition for treatment of prostate cancer
Aleksei Ehduardovich Machulkin, Kamensk-Uralskii (RU); Anastasiia Alekseevna Uspenskaia, Kamensk-Uralskii (RU); Elena Sergeevna Khazanova, Moscow (RU); Aleksei Alekseevich Rybalov, Nevinnomyssk (RU); Svetozar Olegovich Pchelintsev, Konakovo (RU); Stanislav Aleksandrovich Petrov, Krasnodarskii krai (RU); Anton Petrovich Ber, Ust-Vymskii r-n (RU); Nikolai Petrovich Zyk, Moscow (RU); Ian Andreevich Ivanenkov, Moscow (RU); Dmitrii Aleksandrovich Skvortsov, Moscow (RU); Aleksandr Sergeevich Erofeev, Moscow (RU); Petr Vladimirovich Gorelkin, Moscow (RU); Elena Kimovna Beloglazkina, Moscow (RU); and Aleksandr Georgievich Mazhuga, Moscow (RU)
Assigned to IZVARINO FARMA AB, Malmö (SE)
Filed by IZVARINO FARMA AB, Malmö (SE)
Filed on May 20, 2022, as Appl. No. 17/749,958.
Application 17/749,958 is a continuation of application No. PCT/RU2020/000473, filed on Sep. 8, 2020.
Claims priority of application No. 2019137590 (RU), filed on Nov. 22, 2019.
Prior Publication US 2022/0281852 A1, Sep. 8, 2022
Int. Cl. C07D 403/12 (2006.01); A61K 47/10 (2017.01); A61K 47/32 (2006.01)
CPC C07D 403/12 (2013.01) [A61K 47/10 (2013.01); A61K 47/32 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A compound represented by the following formula (I) or a salt thereof:

OG Complex Work Unit Chemistry